Seonjeong Woo

Songnam, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Clinical significance of gross morphological type beyond tumor burden in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Journal: Clinical and molecular hepatology

Published: July 10, 2026

Clinical utility of liquid biopsy in biliary tract cancer: Diagnosis to treatment monitoring.

Clinical utility of liquid biopsy in biliary tract cancer: Diagnosis to treatment monitoring.

Journal: Clinical and molecular hepatology

Published: March 19, 2026

Correspondence to letter to the editor on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features".

Correspondence to letter to the editor on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features".

Journal: Clinical and molecular hepatology

Published: February 11, 2026

Immune-related adverse events in hepatocellular carcinoma: organ-specific patterns and management approaches.

Immune-related adverse events in hepatocellular carcinoma: organ-specific patterns and management approaches.

Journal: Journal of liver cancer

Published: October 31, 2025

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer.

Journal: Clinical and molecular hepatology

Published: September 09, 2025

Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study.

Biology-driven stratification of advanced biliary tract cancer treated with nab-paclitaxel plus gemcitabine-cisplatin: A prospective observational cohort study.

Journal: Hepatology (Baltimore, Md.)

Published: August 26, 2025

Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features.

Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features.

Journal: Clinical and molecular hepatology

Published: July 17, 2025

Epidemiology and genomic features of biliary tract cancer and its unique features in Korea.

Epidemiology and genomic features of biliary tract cancer and its unique features in Korea.

Journal: Journal of liver cancer

Published: February 07, 2025

Reply to: Correspondence on 'Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer'.

Reply to: Correspondence on 'Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer'.

Journal: Journal of hepatology

Published: February 03, 2025

Osteoblast-Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation.

Osteoblast-Derived Mitochondria Formulated with Cationic Liposome Guide Mesenchymal Stem Cells into Osteogenic Differentiation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 09, 2024

Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer.

Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer.

Journal: Journal of hepatology

Published: January 11, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026